Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

4.105 +0.045 (+1.11%)
Streaming Delayed Price Updated: 1:35 PM EDT, Jun 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,270,705
Open 4.170
Bid (Size) 4.100 (7,900)
Ask (Size) 4.110 (2,100)
Prev. Close 4.060
Today's Range 4.030 - 4.180
52wk Range 2.000 - 6.750
Shares Outstanding 166,010,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
From AtaiBeckley Inc.
Via GlobeNewswire

Performance

YTD
+6.1%
+6.1%
1 Month
-5.0%
-5.0%
3 Month
+21.1%
+21.1%
6 Month
-4.5%
-4.5%
1 Year
+103.2%
+103.2%

More News

Read More
News headline image
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
These 3 Psychedelic Stocks Activated After Trump's Executive Order ↗
Via MarketBeat
Topics Government
News headline image
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research
From AtaiBeckley Inc.
Via GlobeNewswire
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up ↗
Via Chartmill
News headline image
Why AtaiBeckley Stock Surged Today ↗
Via The Motley Fool
Topics Government
News headline image
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
Via AB Newswire
News headline image
This 4/20, Wall Street Is Betting on More Than Marijuana ↗
Via MarketBeat
News headline image
AtaiBeckley Stock Skyrockets After Cantor Fitzgerald's Overweight Rating ↗
Via Benzinga
Topics Government
What's going on in today's session ↗
Via Chartmill
News headline image
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar ↗
Via The Motley Fool
Topics Government
These stocks are gapping in today's session ↗
Via Chartmill
Top movers in Monday's pre-market session ↗
Via Chartmill
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
News headline image
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
Via AB Newswire
News headline image
AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley To Host Virtual Investor Day on March 6, 2026
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley To Participate in Upcoming Investor Conferences
From AtaiBeckley N.V.
Via GlobeNewswire

Frequently Asked Questions

Is AtaiBeckley Inc. - Common Stock publicly traded?
Yes, AtaiBeckley Inc. - Common Stock is publicly traded.
What exchange does AtaiBeckley Inc. - Common Stock trade on?
AtaiBeckley Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AtaiBeckley Inc. - Common Stock?
The ticker symbol for AtaiBeckley Inc. - Common Stock is ATAI on the Nasdaq Stock Market
What is the current price of AtaiBeckley Inc. - Common Stock?
The current price of AtaiBeckley Inc. - Common Stock is 4.105
When was AtaiBeckley Inc. - Common Stock last traded?
The last trade of AtaiBeckley Inc. - Common Stock was at 06/22/26 01:35 PM ET
What is the market capitalization of AtaiBeckley Inc. - Common Stock?
The market capitalization of AtaiBeckley Inc. - Common Stock is 681.47M
How many shares of AtaiBeckley Inc. - Common Stock are outstanding?
AtaiBeckley Inc. - Common Stock has 681M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.